Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Mindray Medical Reports Much Higher 2008

publication date: Jan 12, 2009

Mindray Medical International Limited (迈瑞医疗国际有限公司) reported preliminary 2008 results for its medical device business, showing that the company continued to perform well, despite the difficult economic environment. Mindray expects 2008 revenues to be in the range of $540 million to $550 million, an 85% jump. For net income, Mindray is predicting non-GAAP EPS will be at least $1.16, a 47% increase over the 2007 figure. More details...

Stock Symbols: (NYSE: MR) (NSDQ: DSCP)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital